Cytek Biosciences Inc (CTKB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 49,693 | 37,088 | 48,336 | 40,477 | 40,159 |
| Cost of Goods | 21,531 | 16,050 | 18,962 | 13,615 | 15,598 |
| Gross Profit | 28,162 | 21,038 | 29,374 | 26,862 | 24,561 |
| Operating Expenses | 37,820 | 33,250 | 30,252 | 26,117 | 26,050 |
| Operating Income | -9,127 | -12,162 | 84 | 1,360 | -891 |
| Interest Expense | 409 | 673 | 687 | 649 | 647 |
| Other Income | 2,941 | 3,795 | 4,717 | 1,139 | 137 |
| Pre-tax Income | -6,595 | -9,040 | 4,114 | 1,850 | -1,401 |
| Income Tax | -2,207 | -2,233 | 396 | 224 | -699 |
| Net Income Continuous | -4,388 | -6,807 | 3,718 | 1,626 | -702 |
| Minority Interests | N/A | N/A | 189 | -40 | -104 |
| Net Income | $-4,388 | $-6,807 | $3,529 | $1,666 | $-598 |
| EPS Basic Total Ops | -0.03 | -0.05 | 0.03 | 0.01 | 0.00 |
| EPS Basic Continuous Ops | -0.03 | -0.05 | 0.03 | 0.01 | -0.01 |
| EPS Diluted Total Ops | -0.03 | -0.05 | 0.03 | 0.01 | 0.00 |
| EPS Diluted Continuous Ops | -0.03 | -0.05 | 0.03 | 0.01 | -0.01 |
| EBITDA(a) | $-6,682 | $-10,361 | $1,948 | $2,131 | $663 |